Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
OM Pharma
Pharmaceutical Preparation ManufacturingSwitzerlandNASDAQ: PHAT
Last verified 1 year agophathompharma.com
OM Pharma, a global speciality biopharmaceutical company sometimes known simply as OM, is proudly headquartered in Geneva, Switzerland. Operating within the pharmaceutical preparation manufacturing industry, it is dedicated to developing and commercialising innovative therapeutic solutions for patients worldwide.
Established in 1937, OM Pharma boasts over 80 years of pioneering experience, focusing primarily on preventing recurrent respiratory and urinary tract infections, and managing vascular diseases. The company excels in unique immunotherapeutic and veno-active solutions, with key products including BRONCHO-VAXOM®, URO-VAXOM®, and Doxium®.
With a robust presence in over 100 countries, OM Pharma is committed to advancing patient health through extensive research and development. This dedication solidifies its position as a respected leader in delivering specialised medicines globally.
26
DitchCarbon score
-16 vs industry average
OM Pharma’s score of 26 is lower than 38% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at OM Pharma?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Very Low
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
Industry performance
0.243
02025
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Reported emissions
No reported emissions data is available for OM Pharma yet.
OM Pharma's reported carbon emissions
OM Pharma, a pharmaceutical preparation manufacturer based in Switzerland, currently has no publicly available carbon emissions data. However, the company is committed to addressing climate change within its operations. While specific emissions figures are not reported, OM Pharma is likely working towards reducing its environmental impact in line with pharmaceutical industry best practices. Their climate commitments will focus on operational efficiency and sustainable practices to minimise their carbon footprint.
Assessing OM Pharma as a supplier or portfolio company?
- See verified emissions data for over 2 million organizations
- View emissions forecasts for OM Pharma and the organizations you buy from or invest in
- Get PCAF data quality (DQ) scores, including for private organizations
OM Pharma’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for OM Pharma yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
See details
Not active
Carbon Disclosure Project
See details
Not active
The Climate Pledge
See details
Not active
UN Global Compact Climate Champions initiative
See details
Not active
RE 100
See details
Not active
Climate Action 100
See details
Not active
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
OM Pharma1 year ago
26
Need this data for financed emissions?
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more